[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-eADLAt76rrnBE-VF9IGYK9MG3TToYQbnDhXIk1Znhc":8,"$fSm8ruI0NSj1C1HCs99d-vgxtZ4fqRWDVtqoN9eC25mI":55,"$fYb4Dr-XT-U_q-wWj7MSVjedaFPpOMhgb8wT8P9qS0as":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67209,870419,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","张澄","杭州师范大学附属医院","肿瘤科","主治医师",22,0,"深入了解恶性肿瘤维持性化学治疗：定义与实用指导","","https://ystcdn.venuertc.com/venue/AI/6cddc7a8-3dc7-4c35-874c-403c235852b1.jpg","\u003Cdiv id=\"material_title\" class=\"drug-maintain-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">深入了解恶性肿瘤维持性化学治疗：定义与实用指导\u003C/h2>\n  \u003Cp class=\"drug-maintain-lead\">化学治疗是许多人耳熟能详的肿瘤治疗手段，而所谓“维持性化学治疗”，其实是指在初次化学药物治疗结束后继续使用药物来巩固疗效。今天，我们就以实际用药为例，深入聊聊维持性化学治疗的药品操作细节，包括用药方式、剂型、常见副作用、药物相互作用等7个核心点。了解这些内容，可以让用药过程更加安全、安心。\u003C/p>\n\u003C/div>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 维持性化学治疗：药品策略简述 🎯\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cp>\n      维持性化学治疗（Maintenance Chemotherapy）是指在化学治疗获得初步效果后，为防止肿瘤细胞再生和复发，继续按方案定期给药。这一策略的核心是延长有效控制期，降低肿瘤负荷。通常，选择作用机制明确、副作用较易控制的药物，在较低剂量下长期应用，目的在于延续药物抑制肿瘤的作用。\u003Cbr>\n      \u003Cspan class=\"drug-maintain-highlight\">正确做法：\u003C/span> 按医生制定的用药周期和剂量坚持规范用药，不擅自增减药量、不漏服停服，整个用药周期一般较长，每周期之间也需休息和检查。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 适合人群和用药选择🧑‍⚕️\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cp>\n      通常，\u003Cspan class=\"drug-maintain-highlight\">经过初步化疗达至稳定状态\u003C/span>的患者，主治医生会根据上一阶段的治疗反应、身体状况、安全性和生活质量等因素，判断是否进入维持期。用药方案会个体化调整，常见选择既有口服制剂，也有静脉制剂。\u003Cbr>\n      \u003Cspan class=\"drug-maintain-highlight\">正确做法：\u003C/span> 接受主治医师的用药评估，明晰适合自己的药品方案和剂量，定期复查以便药物方案随时调整。\n    \u003C/p>\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>✔️ 配合周期治疗，切忌随意终止或自行调整药物；\u003C/li>\n      \u003Cli>✔️ 详细了解每一种药品的具体用法用量。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-maintain-case\">临床案例：一位39岁男性，完成初始化疗后采用每日口服200mg胶囊+静滴配合维生素B6复合制剂，结合周期用药方式，按规定周期规范服药。\u003C/div>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 维持性化学治疗药品梳理 💊\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cp>\n      用于维持性化学治疗的药品按剂型主要有口服胶囊、片剂，以及静脉制剂（如注射液）。功效上，主要分为细胞毒类和分子靶向类两大类。 \n    \u003C/p>\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>⭕ \u003Cstrong>细胞毒类药物：\u003C/strong> 如环磷酰胺（Cyclophosphamide）、长春新碱（Vincristine），通过干扰癌细胞分裂抑制增殖。\u003C/li>\n      \u003Cli>⭕ \u003Cstrong>分子靶向类药物：\u003C/strong> 如伊马替尼（Imatinib）、厄洛替尼（Erlotinib），专门抑制肿瘤细胞特定分子路径的活性。\u003C/li>\n      \u003Cli>⭕ \u003Cstrong>辅助药物：\u003C/strong> 化疗期间常配合维生素B6、氯化钠注射液等，帮助减轻副作用、保护器官功能。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">正确做法：\u003C/span> 明确自己的药品类别和剂型，按标准流程操作用药。如口服片剂需用温水整片吞服；静脉输注严格遵守操作无菌要求。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 服药时间与用法用量⏰\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>\n        \u003Cstrong>服药时间：\u003C/strong>依药品而定，有些要求固定每日同一时段，有些需餐前或餐后，确保药物生物利用度最优。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>口服用药：\u003C/strong>以200mg胶囊为例，通常每日一次（QD），整粒吞服，不可嚼碎。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>静脉用药：\u003C/strong>输液港操作须提前检查无堵塞感染，调配好如0.9%氯化钠注射液（250ml），静脉滴注速度按方案执行。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>辅助药物：\u003C/strong>维生素B6、氯化钠等参照医嘱剂量和次数可每日静滴。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">需要注意：\u003C/span>不能漏服、不能突然停药。发现漏服应及时补服（但若接近下次给药，则跳过，不要一次双倍服药）。\n    \u003C/p>\n    \u003Cdiv class=\"drug-maintain-case\">实际经验：如某日口服药不慎漏服，可在当天数小时内补服，若已过6小时则不补，直接按下次剂量继续。\u003C/div>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用与组合禁忌🧪\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cp>\n      药物联合时存在相互影响，如部分抗生素、抗癫痫药、草本制品等可影响维持化疗药物的作用强度或毒性。举例来说，酮康唑等CYP3A4抑制剂可提升某些分子靶向药物的血药浓度，增加副作用风险。\n    \u003C/p>\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>\n        \u003Cspan class=\"drug-maintain-tip\">🚫\u003C/span> 同时服用影像对比剂、强效抗生素、部分抗病毒药等需谨慎，可能导致不良反应增加或药效降低。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"drug-maintain-tip\">💡\u003C/span> 建议用药期间如需加用新药，必须告知医生，避免潜在危险。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">正确做法：\u003C/span> 用药过程中不随意添加保健品、中草药，更换或调整用药时提前与医生沟通。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 典型不良反应与紧急处理方法⚠️\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cp>\n      维持性化学治疗期间，不良反应并不罕见。比较典型的包括：\n    \u003C/p>\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>低白细胞、贫血：表现为抵抗力下降，但轻度者可无症状。\u003C/li>\n      \u003Cli>恶心、食欲减退、乏力：部分口服制剂更易引起，需要观察。\u003C/li>\n      \u003Cli>皮疹、脱发、轻度口腔溃疡：体质差异较大。\u003C/li>\n      \u003Cli>肝肾功能波动：长期服用需动态监测。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">数据提示：\u003C/span>分子靶向药物的不良反应（如厄洛替尼）发生率高达30-40%，但大部分通过减量、停药或辅助药物可有效控制\u003Csup>[1]\u003C/sup>。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">处理建议：\u003C/span> 若出现骨髓抑制（白细胞<3.0x10\u003Csup>9\u003C/sup>/L等）、出血点、皮疹严重或剧烈呕吐，应及时就医，切勿自行停药。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 患者自我管理和日常注意📋\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cp>\n      进入维持性化疗阶段，患者及家属科学自我管理非常关键。具体包括：\n    \u003C/p>\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>\n        \u003Cstrong>随时记录用药：\u003C/strong> 可用手机日历、纸质本，将每次服药/输液时间、剂量、感觉做简要记载。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>规律监测体征：\u003C/strong> 如每日血压、体温、一般体力及味觉变化，有异常及时反馈医生。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>饮食营养搭配：\u003C/strong> 饮食以清淡高蛋白、易消化为宜，多吃新鲜果蔬，避免辛辣、刺激性强食物。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>保持良好心理状态：\u003C/strong> 坚持日常作息，适度运动，调节压力有助于药品耐受。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-maintain-case\">实际用药反馈：不少患者采用记录本或手机APP打卡功能，能有效杜绝漏服漏注，有助于主治医生调整处方。\u003C/div>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">特别提醒：\u003C/span> 各项辅助治疗（如维生素、保肝药）不要自行断停或增减；如有任何身体不适，应第一时间联系医务人员。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存要求和有效期管理 🗂️\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>\n        \u003Cstrong>口服药物：\u003C/strong> 置于室温干燥、避光环境，远离儿童和易污染区域。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>注射液及配成液体制剂：\u003C/strong> 建议冷藏（2-8°C），开封后24小时未用完应弃置。不可置于冷冻环境。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>有效期：\u003C/strong> 及时检查药盒批号及生产日期，过期药品应送回药房，避免自行处理。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>药物耗材：\u003C/strong> 输液针、敷料每次用后弃置，遵守无菌原则，防止交叉感染。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">正确做法：\u003C/span> 定期查验药物外观、包装和有效期，与日常家用品分开存放，严控儿童误服风险。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 老年人及肝肾功能异常者的用药调整🧓\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>\n        老年人机体代谢较慢，肝肾功能变化较大，维持化疗药物多需调低剂量、增加监测。部分药品（如伊马替尼）在肾功能减退时需谨慎应用。\u003C/li>\n      \u003Cli>\n        用药期间定期查肝肾功能（建议每两周一次），调整剂量须由主治医生评估后实施。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">正确做法：\u003C/span> 向医务人员如实反映既往基础疾病、用药史，主动配合相关检查。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-subtitle-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 漏服与过量补救措施⏳\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"drug-maintain-content\">\n    \u003Cul class=\"drug-maintain-list\">\n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong> 通常可在短时间内补服，但已接近下次剂量则不补，按下一次正常服用，不要加倍。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量处理：\u003C/strong> 服用剂量超标或静滴速度过快时，需立刻停药，尽早就医，如果有呕吐、出血点、抽搐等表现需就近急救。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-maintain-case\">某患者因漏服按医嘱补服未致不良反应；但服用剂量翻倍则出现腹泻呕吐，紧急停药得到缓解。\u003C/div>\n    \u003Cp>\n      \u003Cspan class=\"drug-maintain-highlight\">特别提醒：\u003C/span> 任何情况下，不能擅自处理严重用药错误，如怀疑过量务必就医。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-end\">\n    \u003Ch3 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与提醒\u003C/h3>\n    \u003Cul>\n      \u003Cli>\n        维持性化学治疗的药物应用是一项长期、系统的工程。安全规范的用药、仔细的自我观察和随时的医生沟通不可或缺。\u003C/li>\n      \u003Cli>\n        \u003Cmark class=\"drug-maintain-mark\">最重要的是：每次用药严格按方案操作，出现不适坚决不要自行处理，一定要与主治团队联络。\u003C/mark>\n      \u003C/li>\n      \u003Cli>\n        掌握各类药品的规格与剂型，知晓储存、服用、相互作用和不良反应，就能最大程度保障疗效与个人安全。\u003C/li>\n      \u003Cli>\n        建议有疑问时随时咨询专业医务人员，科学用药，让治疗更加可控、可持续。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"drug-maintain-section\">\n  \u003Cdiv class=\"drug-maintain-ref\">\n    \u003Ch3 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col>\n      \u003Cli>Johnson, J. R., & Cohen, M. H., et al. (2005). Approval Summary: Erlotinib for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Failure of at Least One Prior Chemotherapy Regimen. Clinical Cancer Research, 11(18), 6414-6421. \u003Cem>https://doi.org/10.1158/1078-0432.CCR-05-0460\u003C/em>\u003C/li>\n      \u003Cli>O'Brien, S., et al. (2003). Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. New England Journal of Medicine, 348(11), 994-1004.\u003C/li>\n      \u003Cli>Lacy, J., & McFarland, C., et al. (2018). Chemotherapy and Immunotherapy Toxicities and Management. Oncology Nursing Forum, 45(1), 28-37.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/section>\n\n\u003Cstyle>\n.drug-maintain-title {\n  background: #e3eae6;\n  padding: 36px 24px 18px 24px;\n  border-radius: 24px;\n  margin-bottom: 24px;\n}\n.drug-maintain-title h1 {\n  font-size: 2.3rem; color: #1d3d29; font-weight: 900;\n  margin-bottom: 10px;\n  text-shadow: 0 2px 8px #bfcfc6;\n}\n.drug-maintain-lead {\n  font-size: 1.15rem;\n  color: #334d3a;\n}\n\n.drug-maintain-section {\n  margin: 32px auto;\n  max-width: 920px;\n  box-sizing: border-box;\n}\n.drug-maintain-subtitle-bg {\n  background: linear-gradient(90deg, #ebf5f2 60%, #f5f8fb 100%);\n  border-radius: 18px;\n  padding: 16px 28px 14px 28px;\n  margin-bottom: 20px;\n  display: flex;\n  align-items: center;\n  border-left: 6px solid #7fcda1;\n}\n.drug-maintain-subtitle-bg h2 {\n  color: #228161;\n  font-size: 1.45rem;\n  font-weight: 700;\n  margin: 0;\n  letter-spacing: 0.5px;\n}\n.drug-maintain-content {\n  font-size: 1.08rem;\n  color: #203320;\n  line-height: 1.8;\n  padding-left: 15px;\n  padding-right: 15px;\n  padding-bottom: 10px;\n}\n.drug-maintain-highlight {\n  color: #207c56;\n  font-weight: 700;\n  font-size: 1em;\n}\n.drug-maintain-list {\n  list-style: disc;\n  margin: 16px 0 10px 30px;\n  padding: 0;\n  font-size: 1.08em;\n}\n.drug-maintain-list li {\n  margin-bottom: 10px;\n  line-height: 1.6;\n}\n.drug-maintain-tip {\n  font-size: 1.2em;\n  vertical-align: middle;\n  margin-right: 3px;\n}\n.drug-maintain-case {\n  background: #f4faea;\n  color: #526040;\n  border-left: 3px solid #c8e3b2;\n  border-radius: 7px;\n  padding: 11px 22px 11px 20px;\n  margin-top: 14px;\n  margin-bottom: 10px;\n  font-style: italic;\n  font-size: 1em;\n  box-shadow: 0 2px 6px #f0f6ea;\n}\n.drug-maintain-end {\n  background: #e6f7e1;\n  border: 1px solid #bedfbb;\n  border-radius: 10px;\n  margin-top: 16px;\n  padding: 25px 28px;\n}\n.drug-maintain-end h3 {\n  color: #238d36;\n  font-size: 1.16rem;\n  font-weight: 700;\n  margin-bottom: 11px;\n}\n.drug-maintain-mark {\n  color: #8f200b;\n  font-weight: 600;\n  background: #f8e3e0;\n  padding: 2px 10px;\n  border-radius: 5px;\n  margin-left: 6px;\n  margin-right: 6px;\n}\n.drug-maintain-ref {\n  background: #f1f7fb;\n  border-left: 5px solid #85b7e7;\n  margin-top: 35px;\n  padding: 21px 16px 15px 27px;\n  border-radius: 8px;\n  font-size: 0.97rem;\n}\n@media (max-width: 600px) {\n  .drug-maintain-title {\n    padding: 20px 10px 12px 10px;\n    border-radius: 12px;\n  }\n  .drug-maintain-subtitle-bg {\n    padding: 10px 12px 10px 12px;\n    border-radius: 11px;\n  }\n  .drug-maintain-end {\n    padding: 14px 8px;\n    border-radius: 5px;\n  }\n  .drug-maintain-section {\n    margin: 16px 0px;\n    padding: 0;\n  }\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"drug-maintain-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1",528,"2025-09-24 18:01:09","维持性化学治疗, 恶性肿瘤, 化疗药物, 药物相互作用, 不良反应","掌握维持性化学治疗的重要性及实用指导，了解药品策略、适合人群及不良反应，帮助患者科学用药和自我管理，保障治疗效果。","2025-10-10 19:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]